These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7718168)

  • 1. The combined method of transplantation of foetal substantia nigra and stereotactic thalamotomy for Parkinson's disease.
    Wu CY; Zhou MD; Bao XF; Zhang QL; Sun W; Li FZ; Zhao JJ
    Br J Neurosurg; 1994; 8(6):709-16. PubMed ID: 7718168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiological bases, clinical results and indications for surgical treatment in Parkinson disease].
    Obeso JA; Linazasoro G; Gorospe A; Rodríguez MC; Guridi J; Ramos E
    Neurologia; 1999 May; 14 Suppl 1():54-71. PubMed ID: 10377730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical treatment of Parkinson's disease].
    Komai N
    Nihon Rinsho; 1993 Nov; 51(11):2940-6. PubMed ID: 8277575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurotransplantation. III. Intracerebral grafting of fetal substantia nigra in Parkinson's disease].
    Dymecki J; Zabek M; Mazurowski W; Lechowicz W
    Neurol Neurochir Pol; 1994; 28(1):73-86. PubMed ID: 8028708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathology of fetal nigral grafts in patients with Parkinson's disease.
    Kordower JH; Freeman TB; Olanow CW
    Mov Disord; 1998; 13 Suppl 1():88-95. PubMed ID: 9613724
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intraparenchymal and intraventricular transplantation of fetal substantia nigra cell suspension in rat model of Parkinson's disease].
    Yang H; Zhang K; Cai W
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):19-21. PubMed ID: 10374501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplants in Parkinson's disease.
    Lindvall O
    Eur Neurol; 1991; 31 Suppl 1():17-27. PubMed ID: 1855521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural transplantation (auto-adrenal, fetal nigral and fetal adrenal) in Parkinson's disease: the Mexican experience.
    Madrazo I; Franco-Bourland R; Ostrosky-Solis F; Aguilera M; Cuevas C; Alvarez F; Magallon E; Zamorano C; Morelos A
    Prog Brain Res; 1990; 82():593-602. PubMed ID: 1981281
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.
    Baik HM; Choe BY; Lee HK; Suh TS; Son BC; Lee JM
    Korean J Radiol; 2002; 3(3):180-8. PubMed ID: 12271163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stereotactic thalamotomy in the treatment of Parkinson's disease].
    Dong YR; Lin YJ; Li YH
    Zhonghua Wai Ke Za Zhi; 1987 Jul; 25(7):428-9, 446-7. PubMed ID: 3315508
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cell transplantation and stereotaxic neurosurgical procedures for therapy of patients with Parkinson's disease].
    Date I; Matsui T
    Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1448-55. PubMed ID: 13677893
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgical treatment of Parkinson's disease.
    Krauss JK; Jankovic J
    Am Fam Physician; 1996 Oct; 54(5):1621-9. PubMed ID: 8857784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term survival of fetal substantia nigra grafts in striatum of PD rats: an observation of tyrosine hydroxylase immunohistochemistry and western blot].
    Yang H; Cai W; Zhang K
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):13-5. PubMed ID: 10374499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of fetal mesencephalic tissue in Parkinson's disease.
    Freed CR; Breeze RE; Schneck SA
    N Engl J Med; 1995 Sep; 333(11):730-1. PubMed ID: 7637761
    [No Abstract]   [Full Text] [Related]  

  • 15. Surgical treatment of Parkinson's disease.
    Koller WC; Pahwa R; Lyons KE; Albanese A
    J Neurol Sci; 1999 Aug; 167(1):1-10. PubMed ID: 10500254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stereotaxic surgery in 4 cases of Parkinson's disease].
    Meléndez-Manzano JA; González-Ortíz J; Meléndez-Manzano E; Lavalle-Martínez J; Schiaffini-Ruiz MC; Vélez-Quintana Roo JO
    Rev Invest Clin; 1996; 48(6):449-52. PubMed ID: 9132889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repairing the brain in Parkinson's disease: where next?
    Barker RA
    Mov Disord; 2002 Mar; 17(2):233-41. PubMed ID: 11921107
    [No Abstract]   [Full Text] [Related]  

  • 18. Stereotaxic lesions in Parkinson's disease. Clinicopathological correlations.
    Markham CH; Brown WJ; Rand RW
    Arch Neurol; 1966 Nov; 15(5):480-97. PubMed ID: 5333735
    [No Abstract]   [Full Text] [Related]  

  • 19. Fetal homotransplants in the treatment of Parkinson's disease.
    Freeman TB; Olanow GW
    Arch Neurol; 1991 Sep; 48(9):900-2. PubMed ID: 1953410
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of previous stereotactic thalamotomy on l-dopa therapy in Parkinson's disease.
    Selby G
    Proc Aust Assoc Neurol; 1976; 13():55-60. PubMed ID: 800866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.